Abstract. Our previous research found that feruloylated oligosaccharides (FOs) from corn bran modulated the gut microbiota in normal rats. This research aimed to investigate its effect on lipid metabolism and antioxidant activity in the plasma, liver, and heart. The results showed that, compared with the control, oral administration of 300 mg/kg FOs significantly decreased total cholesterol (by 19.8%) and low-density lipoprotein cholesterol (by 29.8%) but did not significantly influence glucose, triacylglycerol, and high-density lipoprotein cholesterol in serum; administration of the dosage to 600 mg/kg did not further change these parameters except for increasing total cholesterol. FOs administration at 300 mg/kg did not influence the content of thiobarbituric acid-reactive substances (TBARS) in plasma, liver, but significantly decreased it and significantly increased glutathione (GSH) in the heart, and superoxide dismutase (SOD) activity in plasma and liver. Interestingly, administration of FOs at 300 and 600 mg/kg decreased nitric oxide (NO) content in the heart but increased it in the plasma and liver. Whether or not the effect of FOs on NO content is beneficial or detrimental warrants further investigation.
Introduction
Feruloylated oligosaccharides (FOs) are derivatives formed through the esterification of ferulic acid to oligosaccharides [1] , it has been approved by US FDA as wheat bran extract and are intended for use as a food ingredient in baked goods and baking mixes, beverages and beverage bases, breakfast cereals, frozen dairy desserts, gelatin and puddings, grain products and pastas, jams and jellies, milk products, processed fruits and fruit juices, processed vegetables and vegetable juices, and snack foods (FDA, GRAS Notice 000343) [2] .
FOs possesses the physiological functions of both ferulic acid (FA) and oligosaccharides [1] . FA as well as FOs from wheat bran have been proved to lower the levels of serum glucose, lipoprotein, and advanced glycation end products in diabetes rats [3] [4] [5] , and in cell lines [6, 7] . Different from free FA, which is mainly absorbed in small intestine [8] , FOs releases FA after fermentation by gut microorganisms [9] , the constant release of FA in the colon and its circulation in blood would keep a stable concentration of ferulic acid in the serum for much longer time than by intake of free FA [10] .
Corn bran is mainly composed of hemicellulose (700 g/kg) and cellulose (280 g/kg), with only a small amount of lignin (<10 g/kg), and contains highest amount ferulic acid among the cereals' bran [11] . Our previous research indicated that FOs prepared from corn bran contains much higher ferulic acid than that from wheat bran, and showed potential prebiotic activity in normal rats [2] . In this research, we aimed to further investigate whether FOs from corn bran would influence lipid metabolism and antioxidant activity in rats.
Materials and Methods

Materials and Chemicals
FA was purchased from Sigma-Aldrich Company (St. Louis, MO, USA). Xylooligosaccharide (XOS, 92%) was obtained from Shandong Longlive Bio-Technology Co., Ltd. (Dezhou, Shandong Province, China). Xylose, arabinose, galactose, glucose, mannose, and fucose were purchased from Aladdin Reagents Database Inc. (Shanghai, China).
Preparation of FOs from Corn Bran
FOs was prepared in accordance with our previous method [7] . In brief, destarched and deproteinized corn bran was suspended in 10 volumes of oxalic acid (0.6 g/100 mL) solution, autoclaved at 121C for 30 min, cooled, and then filtrated using a 200-mesh nylon cloth. The hydrolyzates were ultrafiltered at 5 kD to remove polysaccharides. The filtrate was loaded on a column filled with Amberlite XAD-2 resin, eluted with 10 volumes of deionized water to remove the oxalic acid and partial non-FOs, and then eluted with five volumes of ethanol (50%) to obtain FOs, which were vacuum-concentrated to approximately 35% and then lyophilized.
Animal Groups and Experimental Design
Sprague-Dawley male rats (160-180 g) were purchased from the Experimental Animal Center of Guangdong Province (Guangzhou, China). The animals with three rats per cage were acclimatized for 7 d in an environmentally controlled room maintained at 21 ± 2℃ with a 12 h light-dark cycle. The animals were divided into five groups (n=9). Group 1 received normal feed. Groups 2, 3, 4, and 5 received normal feed and intragastrically administrated with 300 mg/kgbw/d XOS, 300 mg/kgbw/d XOS + 12 mg/kgbw/d FA, 300 mg/kgbw/d FOs, and 600 mg/kgbw/d FOs, respectively. The ingredients were administered each day for five weeks.
Rats were sampled at the end of the dark period (between 8:00 and 9:00 am). The animals were anesthetized with pelltobarbitalum natricum and then sacrificed. Blood was collected and centrifuged at 5000g for 20 min, and the obtained plasma was used for various biochemical measurements. The heart and liver were homogenized in phosphate buffer solution and used for biochemical assessment.
Biochemical Assessment
Test strips (PWE005003P) for the determination of serum glucose were obtained from Roche Group (Shanghai, China). Test kits for the determination of SOD (A001-1), TBARS (A003-2), NO (A013-2), and GSH (A006-1) were obtained from the Nanjing Jiancheng Biological Engineering Research Center (Nanjing, China).
The levels of triacylglycerol (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL), and low-density lipoprotein cholesterol (LDL) in serum were determined using a 7180 model automatic biochemistry analyzer (Hitachi, Tokyo, Japan) as described in our previous research [3] .
Determination of FA in FOs
Fifty milligrams of FOs were saponified with 10 mL of 2 M NaOH at room temperature for 24 h with magnetic stirring. The hydrolysates were acidified to pH 2.0 using HCl and then extracted with ethyl acetate. Ethyl acetate extracts were evaporated to dryness at 40 °C. The samples were dissolved in methanol and determined by HPLC as the total FA. Another aliquot of 50 mg of FOs was dissolved in 10 mL deionized water and then acidified to pH 2.0 using HCl, FA was extracted with ethyl acetate and determined by HPLC as free FA. HPLC determination conditions were the same as we previously described; the content of bound FA was calculated as: the content of total FA minuses the content of free FA.
Determination of Reducing Sugars, Total Sugars, and Monosaccharide Composition in FOs
Reducing sugars were determined using DNS method, and total sugars were determined using DNS method after the FOs were acid-hydrolyzed by 1 M H2SO4 at 100°C for 3 h according to the method used by Van den Borne et al [12] . Monosaccharides in FOs were determined by gas chromatography-mass spectrometry (GC-MS) according to Sun et al. [13] with some modification. 1.0 mL of saponified FOs was hydrolyzed with 4 mL of 4 M trifluoroacetic acid in nitrogen atmosphere at 120C for 6 h. The FOs hydrolysates were evaporated to dryness using a rotary evaporator at 60C and were then mixed with 10 mg of hydroxylamine hydrochloride and 0.5 mL of pyridine at 90C for 30 min. After cooling, acetic anhydride (0.5 mL) was added, the tube was sealed and incubated at 90C for 30 min. The liquid were evaporated to dryness using a rotary evaporator at 60C; 1 mL chloroform was added to dissolve the alditol acetates and then analyzed by gas chromatography-mass spectrometry on an Agilent 7890/5975 gas chromatograph equipped with an HP-5 MS capillary column (30 m × 0.25 mm, 0.25 µm; Agilent Technologies, Palo Alto, CA, USA). Helium was used as the carrier gas at a constant flow rate of 1 mL/min. The oven conditions were set as: an initial temperature of 50C for 2 min, 50C /min to 100℃, and finally 10C /min to 260C for a 10-min bakeout. The inlet temperature was kept constant at 260C, and the MS transfer line was set at 260C. MS acquisition parameters included scanning from m/z 30 to 1000 in the electron impact mode for routine analysis. The concentrations of monosaccharides were quantified using the standard solution of xylose, arabinose, galactose, glucose, mannose, and fucose.
Identification of FOs in Oxalic Acid-hydrolysates
Samples (10 L) were analyzed on a LC-MS system composed of a 4000Q-TRAP mass spectrometer (Applied BiosystemSciex) and a 1100 HPLC system equipped with an Angilent Eclipse XDB-C18 column (2.1 mm×150 mm, 5 μm) using 0.01% formic acid (A) and methanol (B) as mobile phase for the following stepwise gradient elution time scale: at 0 min to 5 min, A:B=90:10 (V:V); 5.1 min to 20 min, A:B=75:25; 20.1 min to 25 min, A:B=68:32; and 25.1 min to 35 min. The flow rate was 0.3 mL/min, and the column temperature was set at 23 C. Full scan MS (MS2SCAN) and selected ion recording was conducted using electrospray ionization (ESI). Mass spectra of the precursor and product ions were obtained to determine the molecular weight of product components and identify FOs in negative mode. The separated FOs (moisture content 3.7%) had an average polymerization degree of 4.5 and contained bound ferulic acid, free ferulic acid, xylose, arabinose, and galactose at 46.8, 8.6, 564.3, 284.6, and 129.0 mg/g, respectively. Two main FOs, feruloylated arabinose (MW=326) and (5-O-FA--L-arabinose)-1, 3-xylose (MW=458) were detected according to HPLC-MS result (Fig. 1 ) and the linkage type reported previously in corn bran 1. The content of feruloylated arabinose to (5-O-FA--L-arabinose)-1, 3-xylose was 9:1 according to their peak area on HPLC (Fig. 1 ). XOS (with moisture content of 8.0% and free FA content of 2.8 mg/g) only contains one monosaccharide (xylose) with xylobiose, xylotriose, and xylotetranose content 363, 318 and 279 g/kg respectively according to the manufacture's instruction.
Results and Discussion
Composition of FOs and XOS
Effect of FOs Serum Glucose and Lipid Metabolic Alteration
Oral administration of rats with FOs at two levels and XOS did not significantly influence the concentration of serum glucose compared with the control; however, feeding XOS along with FA significantly decreased the concentration of serum glucose (Table 1 ). In comparison with the control, feeding rats with 300mg/kg FOs significantly decreased the concentration of TC and LDL but did not significantly change the concentration of TG and HDL in the plasma; all of the levels of lipid parameters were not significantly influenced after increasing the dosage of FOs to 600 mg/kg (Table  1) . Also, FOs showed more effective on decreasing LDL than XOS or XOS along with FA (Table 1) . TBARS (malondialdehyde) is a well-known indicator of lipid peroxidation, and the major antioxidant substances, including SOD and GSH, are regarded as the first line of the antioxidant defense system against reactive oxygen species generated in vivo [14, 15] . In this research, we used these biomarkers to evaluate the effect of feeding FOs on the status of oxidative stress in rats.
Effect of Feeding FOs on the Antioxidant Activity in the Plasma, Liver and Heart of Rats
The results showed that oral administration of FOs did not significantly influence the content of TBARS in the plasma and liver, but significantly reduced its content in heart compared with the control (Table 2, Table 3 ). Moreover, FOs significantly increased the content of GSH in the heart and SOD activity in the plasma and the liver ( Table 2, Table 3 ). However, compared with the oxidatively stressed animals, such as diabetes rats 4, feeding FOs shows less effect on these oxidative biomarkers. 
Beneficial or Detrimental Effect of FOs on NO Content
FOs administration increased NO level in the plasma and liver. Feeding FOs at 300 and 600 mg/kg increased NO concentration by 36.3% and 53.0% in the plasma, and 20% and 70% in the liver respectively ( Table 2, Table 3 ). However, administration of FOs at two levels decreased NO concentration by 62.2% and 59.1% respectively in the heart (Table 3) .
NO is an essential short-lived signaling/regulatory product of a healthy endothelium that is critically important for vascular health. It has numerous molecular functions, including control of servo-regulatory functions (neurotransmission and vascular tone), regulation of gene transcription and mRNA translation, and production of post-translational protein modifications [16] . Decreased production and/or bioactivity of NO indicate endothelial dysfunction and contribute to accelerated atherogenesis [17] . However, high NO levels are toxic to harm healthy cells [16] . Whether or not the effect of FOs on NO content is beneficial or detrimental needs further investigation.
Conclusion
Our research indicated that FOs influenced lipid metabolism and antioxidant activity in rats. Oral administration of 300mg/kg FOs significantly decreased serum TC and LDL and showed more effective on decreasing LDL than feeding XOS or XOS along with FA. However, increasing the feeding dosage to 600mg/kg FOs showed no lipid-lowering effect. FOs significantly reduced TBARS while significantly increased GSH in the heart and SOD activity in the plasma, and the liver. FOs administration increased NO in the plasma and liver but decreased it in the heart.
